NYMXF (Nymox Pharmaceutical) Cyclically Adjusted Book per Share: $-0.01 (As of Dec. 2024)


What is Nymox Pharmaceutical Cyclically Adjusted Book per Share?

Nymox Pharmaceutical NYMXF Cyclically Adjusted Book per Share is $-0.01 as of Dec. 2024.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Nymox Pharmaceutical's adjusted book value per share for the three months ended in Dec. 2024 was $-0.072. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-0.01 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-10), Nymox Pharmaceutical's current stock price is $0.12. Nymox Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was $-0.01. Nymox Pharmaceutical's Cyclically Adjusted PB Ratio of today is .


Nymox Pharmaceutical  (OTCPK:NYMXF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Nymox Pharmaceutical Cyclically Adjusted Book per Share Related Terms


Nymox Pharmaceutical Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Nymox Pharmaceutical's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nymox Pharmaceutical Cyclically Adjusted Book per Share Chart

Nymox Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 -0.07 -0.04 -0.02 -0.01

Nymox Pharmaceutical Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.02 -0.02 -0.01 -0.01

NYMXF vs LYRA, RNAZ, TOVX: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Nymox Pharmaceutical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nymox Pharmaceutical Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nymox Pharmaceutical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Nymox Pharmaceutical's Cyclically Adjusted PB Ratio falls into.



Nymox Pharmaceutical Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nymox Pharmaceutical's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.072/315.6050*315.6050
=-0.072

Current CPI (Dec. 2024) = 315.6050.

Nymox Pharmaceutical Quarterly Data

Book Value per Share CPI Adj_Book
201409 -0.140 238.031 -0.186
201412 -0.128 234.812 -0.172
201503 -0.076 236.119 -0.102
201506 -0.061 238.638 -0.081
201509 -0.084 237.945 -0.111
201512 -0.055 236.525 -0.073
201603 -0.042 238.132 -0.056
201606 -0.056 241.018 -0.073
201609 -0.038 241.428 -0.050
201612 -0.005 241.432 -0.007
201703 -0.023 243.801 -0.030
201706 -0.014 244.955 -0.018
201709 0.000 246.819 0.000
201712 -0.022 246.524 -0.028
201803 -0.018 249.554 -0.023
201806 0.058 251.989 0.073
201809 0.063 252.439 0.079
201812 0.108 251.233 0.136
201903 0.149 254.202 0.185
201906 0.109 256.143 0.134
201909 0.080 256.759 0.098
201912 0.048 256.974 0.059
202003 0.020 258.115 0.024
202006 -0.015 257.797 -0.018
202009 0.050 260.280 0.061
202012 0.028 260.474 0.034
202103 0.000 264.877 0.000
202106 0.056 271.696 0.065
202109 0.019 274.310 0.022
202112 -0.006 278.802 -0.007
202203 -0.015 287.504 -0.016
202206 0.024 296.311 0.026
202209 0.008 296.808 0.009
202212 -0.005 296.797 -0.005
202303 -0.020 301.836 -0.021
202306 -0.032 305.109 -0.033
202309 -0.020 307.789 -0.021
202312 -0.034 306.746 -0.035
202409 -0.067 315.301 -0.067
202412 -0.072 315.605 -0.072

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $-0.01 mean?
Nymox Pharmaceutical (NYMXF) has a Cyclically Adjusted Book per Share of $-0.01 as of Dec. 2024. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Nymox Pharmaceutical and its competitors.
Is Nymox Pharmaceutical's Cyclically Adjusted Book per Share too high?
Nymox Pharmaceutical's current Cyclically Adjusted Book per Share is $-0.01.
How does Nymox Pharmaceutical's Cyclically Adjusted Book per Share compare to LYRA and RNAZ?
Nymox Pharmaceutical's Cyclically Adjusted Book per Share of $-0.01 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Nymox Pharmaceutical and its competitors. Nymox Pharmaceutical's current Cyclically Adjusted Book per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nymox Pharmaceutical stock overvalued right now?
Nymox Pharmaceutical (NYMXF) has a current Cyclically Adjusted Book per Share of $-0.01. The current Cyclically Adjusted Book per Share is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Nymox Pharmaceutical (NYMXF), the current Cyclically Adjusted Book per Share is $-0.01 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nymox Pharmaceutical Business Description

Address Bay & Deveaux Streets, Nassau, BHS
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and low-grade localized prostate cancer. The company also has an extensive patent portfolio covering its investigational drug as well as other therapeutic and diagnostic indications. It also has U.S. and patent rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The company operates in one reportable segment, focused on researching and developing products for the aging population.